Integrated Safety Analysis of Filgotinib in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis Over a Treatment Duration of up to 5 Years
{{output}}
Objective: To evaluate long-term safety of filgotinib as treatment of moderately to severely active rheumatoid arthritis (RA) for up to 5 years in Japanese patients. ... ...
